Mutant Lipooligosaccharide-Based Conjugate Vaccine Demonstrates a Broad-Spectrum Effectiveness against Moraxella catarrhalis

There is no licensed vaccine available against Moraxella catarrhalis, an exclusive human pathogen responsible for otitis media in children and respiratory infections in adults. We previously developed conjugate vaccine candidates based on lipooligosaccharides (LOSs) of M. catarrhalis serotypes A, B,...

Full description

Saved in:
Bibliographic Details
Main Authors: Ren, Dabin, Yu, Shengqing, Gao, Song, Peng, Daxin, Petralia, Ronald S., Muszynski, Artur, Carlson, Russell W., Robbins, John B., Tsai, Chao-Ming, Lim, David J., Gu, Xin-Xing
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3109615/
https://ncbi.nlm.nih.gov/pubmed/21501641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.03.102
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items